Comparison of different treatment protocols in the treatment of idiopathic detrusor overactivity: A randomized controlled trial

Clinical Rehabilitation

Volumn 25, Issue 4, 2011, Pages 327-338

  Kaya, Serap ^a   Akbayrak, Türkan ^a   Beksaç, Sinan ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Faculty of Medicine   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; NORTROPANE DERIVATIVE; TROSPIUM CHLORIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROMYOGRAPHY; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; KINESIOTHERAPY; MEDICAL RECORD; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERACTIVE BLADDER; PELVIS FLOOR; PHYSIOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TURKEY (REPUBLIC);

COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; ELECTROMYOGRAPHY; EXERCISE THERAPY; FEMALE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NORTROPANES; PELVIC FLOOR; PROSPECTIVE STUDIES; QUALITY OF LIFE; TURKEY; URINARY BLADDER, OVERACTIVE;

EID: 79953886310     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215510385481     Document Type: Article

References (49)

1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78. (Pubitemid 34195211)
2. Jabs CFI, Stanton SL. Urge incontinence and detrusor instability. Int Urogynecol J 2002; 12: 58-68. (Pubitemid 32219747)
3. Bulmer P, Abrams P. The unstable detrusor. Urol Int 2004; 72: 1-12. (Pubitemid 38134882)
4. Herbison P, Hay-Smith J, Ellis G, Moore KH. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003; 326: 841-44. (Pubitemid 36461413)
5. Morris AR, O'Sullivan R, Dunkley P, Moore KH. Extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial. Eur Urol 2007; 52: 876-81.
6. Duckett JR, Tamilselvi A. Effect of tension-free vaginal tape in women with a urodynamic diagnosis of idiopathic detrusor overactivity and stress incontinence. BJOG 2006; 113: 30-3.
7. Cardozo L, Chapple CR, Toozs-Hobson P et al. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial. BJU Int 2000; 85: 659-64. (Pubitemid 30192830)
8. Halaska M, Ralph G, Wiedemann A et al. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 2003; 20: 392-99. (Pubitemid 44175311)
9. Yarker YE, Goa KL, Fitton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its theurapeutic use in detrusor instability. Drugs Aging 1995; 6: 243-62.
10. Yalçin OT, Hassa H, Saraç I. Short-term intravaginal maximal electrical stimulation for refractive detrusor insatability. Int J Gynaecol Obstet 2002; 79: 241-44. (Pubitemid 35365778)
11. Frewen W. Role of bladder training in the treatment of the unstable bladder in the female. Urol Clin N Am 1979; 6: 273-79.
12. Berghmans LCM, Hendriks HJM, De Bie RA, van Waalwijk van Doorn ES, Bø K, van Kerrebroeck PE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. BJU Int 2000; 85: 254-63. (Pubitemid 30088515)
13. Alhasso AA, McKinlay J, Patrick K, Stewart L. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006; 4: CD003193.
14. Arruda RM, Castro R, Sartori M, Girão MJ. Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: e review. Curr Opin Obstet Gynecol 2009; 21: 412-14.
15. Chancellor MB, Hasenau DL. Is behavioral therapy plus antimuscarinic better than drug alone to treat overactive bladder? Rev Urol 2008; 10: 306-8.
16. Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008; 148: 459-73. (Pubitemid 351665445)
17. Bø K, Sherburn M. Evaluation of female pelvicfloor muscle function and strength. Phys Ther 2005; 85: 269-82. (Pubitemid 40333546)
18. Polden M, Mantle J. Continence and incontinence. In Polden M, Mantle J. eds. Physiotherapy in obstetrics and gynaecology. Oxford: Butterworth-Heinemann, 1994, 335-87.
19. Jørgensen L, Lose G, Anders J. One hour-pad weighing test for objective assessment of female urinary incontinence. Obstet Gynecol 1987; 69: 39-43.
20. Wagner TH, Patric DL, Bavendam TG, Martin ML, Buesching DP. Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996; 47: 67-72. (Pubitemid 26038306)
21. Karan A, Aksac B, Ayyildiz H, Isikoglu M. Quality of life and its relation with objective assessment parameters in urinary incontinent patients. Turk J Geriatr 2000; 3: 102-6.
22. Akbayrak T, Yüksel I, Demirtürk F. The short-term effects of physical therapy in different intensities of urodynamic stress incontinence. Gynecol Obstet Invest 2005; 59: 43-8.
23. Demirtürk F, Akbayrak T, Karakaya IC et al. Interferential current versus biofeedback results in urinary stress incontinence. Swiss Med Wkly 2008; 138: 317-21. (Pubitemid 351871426)
24. Dumoulin C, Seaborne DE, DeGirardi CQ, Sullivan SJ. Pelvic-floor rehabilitation, Part 1: Comparison of two surface electrode placements during stimulation of the pelvic-floor musculature in women who are continent using bipolar interferential currents. Phys Ther 1995; 75: 1067-74. (Pubitemid 26001338)
25. Mauroy B, Devillers P, Demetriou D, Ametepe B, Biserte J. Treatment of bladder instability with interferential current. Report of 20 cases: preliminary results. Prog Urol 1992; 2: 664-70.
26. Zimmern P, Litman HJ, Mueller E, Norton P, Goode P. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int 2009; 105: 1680-85.
27. Sampselle CM. Behavioral intervention for urinary incontinence for women: evidence for practice. J Midwifery Womens Health 2000; 45: 94-103.
28. Alloussi S, Laval KU, Eckert R et al. Trospium chloride (Spasmo-lyt®) in patients with motor urge syndrome (detrusor instability): double-blind, randomized, placebo-controlled study. J Clin Res 1998; 1: 439-51. (Pubitemid 29078044)
29. Millard RJ, Oldenburg BF. The symptomatic, urodynamic and psychodynamic results of bladder re-education programs. J Urol 1983; 130: 715-19. (Pubitemid 13009785)
30. Arruda RM, Castro RA, Sartori MG et al. Clinical and urodynamic evaluation of women with detrusor instability before and after functional pelvic floor electrostimulation. Clin Exp Obstet Gynecol 2003; 30: 220-22. (Pubitemid 37456321)
31. Ozdedeli S, Karapolat H, Akkoc Y. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study. Clin Rehabil 2010; 24: 342-51.
32. Freeman RM, Adekanmi OA. Overactive bladder. Best Pract Res Clin Obstet Gynaecol 2005; 19: 829-41. (Pubitemid 43012994)
33. Brown JS, McNaughton KS, Wyman FJ. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology 2003; 61: 802-9. (Pubitemid 36384977)
34. Geirsson G, Fall M. Maximal functional electrical stimulation in routine practice. Neurourol Urodyn 1997; 16: 559-65. (Pubitemid 27459442)
35. Elgamasy AN, Lewis V, Hassouna ME, Ghoniem GM. Effect of transvaginal stimulation in the treatment of detrusor instability. Urol Nurs 1996; 16: 127-30.
36. Nygaard IE, Kreder KJ, Lepic MM, Fountain KA, Rhomberg AT. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence. Am J Obstet Gynecol 1996; 174: 120-25. (Pubitemid 26037699)
37. Zinner N, Gittelman M, Haris R, Susset J, Kanelos A, Auerbach S. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. J Urol 2004; 171: 2311-15. (Pubitemid 38625460)
38. Grape HH, Dedering A, Jonasson AF. Retest reliability of surface electromyography on the pelvic floor muscles. Neurourol Urodyn 2009; 28: 385-99.
39. Peschers UM, Gingelmaier A, Jundt K, Leib B, Dimpfl T. Evaluation of pelvic floor muscle strength using four different techniques. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 27-30. (Pubitemid 32219741)
40. Theofrastous JP, Wyman JF, Bump RC et al. Effects of pelvic floor muscle training on strength and predictors of response in the treatment of urinary incontinence. Neurourol Urodyn 2002; 21: 486-90.
41. Padda BS, Jung S, Pretorius D, Nager CW, Den-Boer D, Mittal RK. Effects of pelvic floor muscle contraction on anal canal pressure. Am J Physiol Gastrointest Liver Physiol 2007; 292: 565-71.
42. Prajsner A, Radziszewski P. Ambulatory diagnosis of urinary incontinence among women: the role of a one hour pad weigh test. Wiad Lek 1998; 51: 254-59.
43. Oh-Oka H. Efficacy of interferential low frequency therapy for elderly wet overactive bladder patients. Indian J Urol 2008; 24: 178-81.
44. Goldman HB, Amundsen CL, Mangel J et al. Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms. Neurourol Urodyn 2008; 27: 499-503.
45. Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 2007; 100: 1302-6. (Pubitemid 350043916)
46. Jonasson A, Larsson B, Pschera H, Nylund L. Short-term maximal electrical stimulation-a conservative treatment of urinary incontinence. Gynecol Obstet Invest 1990; 30: 120-23. (Pubitemid 20301035)
47. Khullar V, Chapple C, Gabriel Z, Dooley JA. The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis. Urology 2006; 68: 38-48. (Pubitemid 44189489)
48. Todorova A, Vonderheid-Guth B, Dimpfel W. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 2001; 41: 636-44. (Pubitemid 32493358)
49. Song C, Park JT, Heo KO, Lee KS, Choo MS. Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: a prospective randomized study. J Korean Med Sci 2006; 21: 1060-63.